DRI
53
5
CHRW
56
-3
AA
48
-12
NOC
43
11
EL
25
4
AAP
24
6
KLAC
47
4
PG
56
5
COF
60
2
LB
63
22
LEG
36
4
WAT
55
2
PPL
54
-5
CL
58
2
HRB
57
5
MTB
67
2
DHI
48
4
UPS
60
9
FDX
43
3
LNC
39
3
DRI
53
5
CHRW
56
-3
AA
48
-12
NOC
43
11
EL
25
4
AAP
24
6
KLAC
47
4
PG
56
5
COF
60
2
LB
63
22
LEG
36
4
WAT
55
2
PPL
54
-5
CL
58
2
HRB
57
5
MTB
67
2
DHI
48
4
UPS
60
9
FDX
43
3
LNC
39
3
Financhill
Back

Kairos Pharma Stock Price Chart

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14

KAPA
Kairos Pharma

Last Price:
1.61
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.
  • The current trend is relatively stagnant and KAPA is experiencing slight selling pressure.

Kairos Pharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.69 Sell
20-day SMA: 1.52 Buy
50-day SMA: 0 Buy
200-day SMA: 0 Buy
8-day EMA: 1.59 Buy
20-day EMA: 1.53 Buy
50-day EMA: 1.21 Buy
200-day EMA: 0.49 Buy

Kairos Pharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 49.3 Sell
Chaikin Money Flow: -44456 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.27 - 1.75) Buy
Bollinger Bands (100): ( - ) Buy

Kairos Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Kairos Pharma Stock

Is Kairos Pharma Stock a Buy?

  • Kairos Pharma share price is 1.60 while KAPA 8-day simple moving average is 1.69, which is a Sell signal.
  • The stock price of KAPA is 1.60 while Kairos Pharma 20-day SMA is 1.52, which makes it a Buy.
  • Kairos Pharma 50-day simple moving average is 0.00 while KAPA share price is 1.60, making it a Buy technically.
  • KAPA stock price is 1.60 and Kairos Pharma 200-day simple moving average is 0.00, creating a Buy signal.

KAPA Technical Analysis vs Fundamental Analysis

Sell
14
Kairos Pharma (KAPA) is a Sell

Is Kairos Pharma a Buy or a Sell?

  • Kairos Pharma stock is rated a Sell
    The current Kairos Pharma [KAPA] share price is $1.60. The Score for KAPA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.

Kairos Pharma Stock Info

Market Cap:
20.55M
Price in USD:
1.60
Share Volume:
255.51K

Kairos Pharma 52-Week Range

52-Week High:
4.00
52-Week Low:
1.22
Sell
14
Kairos Pharma (KAPA) is a Sell

Kairos Pharma Share Price Forecast

  • What is the Kairos Pharma stock price today?
    The Kairos Pharma stock price is 1.60 USD today.
  • Will KAPA stock go up or go down?
    Kairos Pharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Kairos Pharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kairos Pharma is overvalued.

Is Kairos Pharma Stock a Buy?

  • Kairos Pharma share price is 1.60 while KAPA 8-day exponential moving average is 1.59, which is a Buy signal.
  • The stock price of KAPA is 1.60 while Kairos Pharma 20-day EMA is 1.53, which makes it a Buy.
  • Kairos Pharma 50-day exponential moving average is 1.21 while KAPA share price is 1.60, making it a Buy technically.
  • KAPA stock price is 1.60 and Kairos Pharma 200-day simple moving average is 0.49, creating a Buy signal.

Fundamental Analysis of Kairos Pharma

Is Kairos Pharma a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.13 per share.

Technical Analysis of Kairos Pharma

Should I short Kairos Pharma stock?

* Kairos Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.